<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The role of epigenetic mechanisms in cognitive functions and neurological/<z:hpo ids='HP_0000708'>psychiatric disorders</z:hpo> has been studied in a number of studies recently </plain></SENT>
<SENT sid="1" pm="."><plain>One of these mechanisms is DNA methylation, for which DNA methyltransferases (DNMT) are responsible </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="50131">Decitabine</z:chebi>, or <z:chebi fb="0" ids="50131">5-aza-2'-deoxycytidine</z:chebi>, is a <z:chebi fb="1" ids="16040">cytosine</z:chebi>-analog DNMT inhibitor and is used in the treatment of certain <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) subsets </plain></SENT>
<SENT sid="3" pm="."><plain>Several studies address the role of DNA methylation and negative effects of <z:chebi fb="0" ids="50131">decitabine</z:chebi> on memory formation and consolidation in animals </plain></SENT>
<SENT sid="4" pm="."><plain>We, therefore, hypothesize that standard <z:chebi fb="0" ids="50131">decitabine</z:chebi> treatment for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> in patients without <z:hpo ids='HP_0000726'>dementia</z:hpo> might cause learning and <z:e sem="disease" ids="C0233794" disease_type="Mental or Behavioral Dysfunction" abbrv="">memory deficits</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>A clinical trial is proposed to test the hypothesis which could support the role of DNA methylation in cognitive abilities of humans </plain></SENT>
</text></document>